Radiological evidence of inflammation related to CAA is relatively common and most cases may go undetected and untreated, a Cleveland Clinic study shows.Read More
An initial characterization of cognitive aging in a rural community cohort in Nevada suggests that late-life rural living may promote cognitive resilience in some.
Psychiatrists say fentanyl test strips can be powerful tool for slowing the scourge of overdoses attributed to tainted street drugs.
A researcher explains the rationale for and goals of her investigations of blood-based biomarkers for Alzheimer’s disease specifically in women.
Findings in a large patient sample implicate sleep-related hypoxia as an important biological pathway of atrial fibrillation and a clinically relevant driver of risk for the condition.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
New study raises concerns about the use of potent coprescriptions to manage insomnia before and during the COVID-19 pandemic.
An early-career Cleveland Clinic researcher has devised a multipronged strategy that integrates advanced computational and experimental approaches to dementia research. The work has attracted $16 million in external grant funding in 2023 alone.
Cognitive and behavioral symptoms often precede motor dysfunction in people who develop Huntington’s disease. A geriatric neuropsychiatrist explains the essentials and how these neuropsychiatric features can be managed.
When evaluating adults with ADHD, researchers urge physicians to focus less on patients’ symptoms and more on their ability to complete tasks.
Psychiatrists marvel at the expanding role of serotonin in our understanding of the human brain and reflect on the molecule’s 75-year history.
Researchers found that rodents use multiple strategies even in advanced stages of learning. They’re now working to apply these insights to neurological diseases in humans.